melatonin/Finding
One finding, on its own
A single claim from the graph, with the grade computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases sleep onset latency
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×8“A significant and clinically relevant shortening of sleep latency to the same extent as most frequently used sleep medications was also found (-24.3 vs.-12.9 minutes; p = 0.028).”
Quoted verbatim from Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.. - Study
- RCT
- Duration
- 3 weeks
- Dose
- prolonged-release melatonin (Circadin) 2 mg once daily, 2 h before bedtime
- Population
- Adults aged 55-80 years with primary insomnia
Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.2007PMID:17875243Permalink
Keep reading
- Everything the graph holds on melatonin
- Every compound studied against Sleep onset latency
- How to read the grade and the marks
To cite this finding: https://catalystproject.ai/e/01M38RZE2Q5SW4GB13VC1ESAJP